ArticleBreast (Edinburgh, Scotland)2026

Impact of anti-HER2 therapies on potentially avoidable deaths from stage II and III HER2-positive breast cancer in the Brazilian public healthcare system.

André Mattar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.